|
13 Feb 2007 |
Medivir Outlicenses The Antiviral Compound MIV-160 To Guangdong Lantai Viewland Pharmaceutical CO. LTD
|
|
13 Feb 2007 |
Rimonabant USA: Update
|
|
11 Feb 2007 |
Nuvo announces update on discussions with FDA related to approval of Pennsaid
|
|
10 Feb 2007 |
Anesiva Presents Data On Pain Drug, 4975, Demonstrating Pain Reduction For Up To Two Weeks After Knee Replacement Surgeries
|
|
10 Feb 2007 |
FibroGen Reports Pharmacologic Stabilization of Hypoxia-Inducible Factor (HIF) Prevents Brain Tissue Damage and Preserves Motor Function in a Preclinical Model of Transient Ischemic Stroke
|
|
09 Feb 2007 |
Clinical Phase I Trial With Hepatitis C Virus Protease Inhibitor Initiated
|
|
09 Feb 2007 |
GlaxoSmithKline and XenoPort announce agreement on late-stage compound for RLS and neuropathic pain
|
|
09 Feb 2007 |
DAIICHI SANKYO returns development rights of KAI-9803
|
|
09 Feb 2007 |
Results of Inhaled Treprostinil Controlled Pilot Studies Reported in the Journal of the American College Of Cardiology
|
|
09 Feb 2007 |
ISTA Pharmaceuticals Announces Positive Preliminary Xibrom(TM) Once-daily Formulation Clinical Results From U.S. Phase III Trials
|
|
09 Feb 2007 |
GlaxoSmithKline and Fabre-Kramer Pharmaceuticals enter global agreement for new treatment of major depressive disorder
|
|
09 Feb 2007 |
SRI International and Telik Announce Exclusive License for SRI to Develop Autoimmune and Inflammatory Disease Drug Candidate
|
|
09 Feb 2007 |
Pfizer's Sutent Receives FDA Approval to Include New First-Line Advanced Kidney Cancer Data in Label
|
|
09 Feb 2007 |
Gilead and Achillion Announce Positive Antiviral Activity of NS4A Antagonist in HCV, But Discontinue GS 9132 (ACH-806) Development
|
|
08 Feb 2007 |
FDA Grants Priority Review to Lovenox(R) (Enoxaparin Sodium Injection) Supplemental New Drug Application (sNDA) for Acute Heart Attack
|
|
08 Feb 2007 |
IntelGenx Technologies Corp. and Cary Pharmaceuticals Inc. Announce Enrollment of Phase I Pilot Study for QuitPak(R) (INT003/05)
|
|
08 Feb 2007 |
FDA Approves Orlistat for Over-the-Counter Use
|
|
08 Feb 2007 |
ViroPharma Receives Orphan Drug Designation for Maribavir for Cytomegalovirus Viremia and Disease Indication
|
|
08 Feb 2007 |
Bioenvision Files with EMeA for Label Extension of Evoltra
|
|
07 Feb 2007 |
Ilypsa, Inc. Completes Enrollment of Phase 2 Clinical Trial of ILY101 for Patients with Chronic Kidney Disease on Hemodialysis: Multi-Center Study Evaluating Safety and Efficacy of Ilypsa's Non-Absorbed Polymeric Drug for Hyperphosphatemia
|
|
07 Feb 2007 |
Spectrum Pharmaceuticals Announces Successful Completion of Patient Accrual in Its EOquin(R) Pilot Study, Prior to Initiating Phase 3 Studies in the U.S.
|
|
07 Feb 2007 |
Avigen Completes Safety, Tolerability and Pharmacokinetic Trial For AV411, a Potential First-in-Class Oral Treatment For Neuropathic Pain
|
|
07 Feb 2007 |
Trigen opens IND for the initiation of a Phase III programme for flovagatran (formerly TGN 255), its novel intravenous direct thrombin inhibitor (DTI)
|
|
06 Feb 2007 |
Amarin Announces Completion Of Two Phase III Trials With Miraxion In Huntington's Disease
|
|
06 Feb 2007 |
Biovitrum and Synphora Initiate Phase II Study of Psoriasis Treatment
|
